GlassScriptPhysician profile
Cesar Garcia
NPI 1477544393
$1,319.22
in general payments reported to CMS, 2019-2025
15 companies · $395 in 2025
The $395 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $276 · 2022: $146 · 2023: $239 · 2024: $263 · 2025: $395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $897.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $897.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $842.85 | 2021-2025 | Eterna, Proclaim, Penta |
| Alexion Pharmaceuticals, INC. | $73.59 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $72.99 | 2023-2024 | Andexxa |
| Boston Scientific Corporation | $44.23 | 2024-2025 | Varithena Administration Pack, Coveredge 32 |
| Medtronic, INC. | $40.86 | 2021-2022 | |
| Si-Bone, INC. | $33.89 | 2023 | |
| Baxter Healthcare | $32.59 | 2021 | |
| Stryker Corporation | $28.31 | 2022-2023 | Duramatrix, Universal Neuro 3, Adherus Autospray Dural Sealant |
| Nevro Corp. | $27.42 | 2023 | Senza |
| Haemonetics Corporation | $25.26 | 2022 | |
| Merck Sharp & Dohme LLC | $22.65 | 2023 | Bridion |
| Globus Medical, INC. | $22.33 | 2021 | |
| Spineology INC. | $20.27 | 2023 | Optimesh Expandable Interbody Fusion System |
| Depuy Synthes Sales INC. | $16.02 | 2024 | Symphony, Vivigen Mis Delivery System |
| Integra Lifesciences Corporation | $15.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cesar Garcia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.